D-0862-2017 Class I Ongoing

Recalled by Hospira Inc. — Lake Forest, IL

FDA drug recall D-0862-2017 was initiated by Hospira Inc. on Apr 21, 2017 and is designated Class I. Reason for recall: Presence of Particulate Matter: human hair found within an internal sample syringe. The recall status is ongoing. Affected quantity: 71,550 syringes.

Recall details

Product Type
Drugs
Report Date
May 31, 2017
Initiation Date
Apr 21, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
71,550 syringes

Product description

Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10

Reason for recall

Presence of Particulate Matter: human hair found within an internal sample syringe.

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot 58382EV*, Exp 1OCT 2017, *lot may be followed by 01 or 02

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0862-2017
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0862-2017. Report a data issue: hello@regdatalab.com.